Search

everythinglearnresearchcommunity

for

Search:↓

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Hormones are crucial for regulating body functions and imbalances can lead to health issues.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

People with hypothyroidism and hair loss often have more hair and scalp issues than those without thyroid problems.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

OCT4 helps granulosa cell growth in early-stage follicles, and FSH increases OCT4 through specific pathways.

Dexamethasone affects hair growth by altering levels of proteins that either promote or inhibit hair follicle growth.

Turning white fat into brown-like fat could help fight obesity and type 2 diabetes.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

Gray hair can potentially be reversed, leading to new treatments.

Follistatin and LIN28B together improve the ability of inner ear cells in mice to regenerate into hearing cells.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Hormones control reproduction and are crucial for body balance.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.